{"url_path":"/sec/vsee/8-k/2026-06-05/item-2-01","section_key":"item-2-01","section_title":"Item 2.01 ****Completion","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1864531/0001185185-26-002359-index.html","accession_number":"0001185185-26-002359","cik":"0001864531","ticker":"VSEE","issuer_name":"VSEE HEALTH, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1864531/0001185185-26-002359-index.html","primary_entity_key":"0001864531","primary_entity_name":"VSEE HEALTH, INC."},"word_count":106,"has_tables":true,"body_markdown":"** **\n\n**Item\n2.01****Completion\nof Acquisition or Disposition of Assets**\n\n** **\n\nThe\ninformation set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 2.01.\n\n \n\nFiled\nas Exhibit 99.1 to this Current Report on Form 8-K is the unaudited pro forma condensed consolidated balance sheet of the Company as\nof March 31, 2026 and the unaudited pro forma condensed consolidated statements of operations of the Company for the three months ended\nMarch 31, 2026, and the year ended December 31, 2025, in each case giving effect to the transaction described under Item 1.01 of this\nCurrent Report on Form 8-K."}